ArticleEuropean journal of haematology2025

Pacritinib Response Is Associated With Overall Survival in Myelofibrosis: PERSIST-2 Landmark Analysis of Survival.

Helen Ajufo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.